Brief: BiomX Announces Dosing Of First Subject In Phase 2 Study Of BX001

Biomx

02/03/2021 12:29

March 2 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX ANNOUNCES DOSING OF FIRST SUBJECT IN PHASE 2 STUDY
OF
BX001 FOR ACNE-PRONE SKIN
    * BIOMX INC - INTERIM DATA READOUT EXPECTED IN Q3 OF 2021

Source text for Eikon:  ID:nBw1rpqKda 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))